The MHRA was pleased to participate in a workshop on 29 June 2026, organised by the British Embassy in Berne, which brought together senior leaders from the biopharma and space sectors, academia, regulatory bodies and funding organisations across the UK …
The UK is taking steps to support the development and manufacture of innovative medicines in microgravity. Through collaborative work between the Medicines and Healthcare products Regulatory Agency (MHRA) and the UK Space Agency, the UK has published the first dedicated …
The refreshed Innovative Licensing and Access Pathway (ILAP) is setting a new global benchmark for accelerating patient access to transformative medicines in the UK. More than just a regulatory pathway, the ILAP is the first end-to-end access pathway that brings …
Recent Comments